Shares of iSpecimen Inc. (ISPC), an online marketplace for human biospecimens, experienced a significant decline of over 19 percent in pre-market trading, dropping to $0.20. This follows the company’s announcement of a reverse stock split at a ratio of 1-for-20, slated to take effect on September 13.The purpose of the reverse stock split is to elevate the per-share value of the company’s stock, thereby making it more attractive to investors and ensuring compliance with the minimum bid price requirement for continued listing on Nasdaq, according to the company’s statement.On Wednesday, iSpecimen stock closed at $0.2421, reflecting a 4 percent decrease. Over the past year, the stock has fluctuated within a range of $0.2000 to $0.7900.The material has been provided by InstaForex Company – www.instaforex.com
- Czech Retail Sales Growth Accelerates in August, Reaching 5.30% - October 8, 2024
- Czech Unemployment Rate Sees Slight Uptick in September - October 8, 2024
- France Sees Rise in Imports: August Figures Show a Notable Increase - October 8, 2024
